Adverse Event Reporting in the Era of Web 2.0: The Challenges of Having a Two-Way Conversation
Presenter: Dr. Elizabeth Garrard
Expiration Date: July 16, 2013
Contact Hours: Earn 1.5 ACRP, CBRN, or CME contact hours (only the purchaser is eligible)
Level: Basic
Cost: $79 Member/$119 Regular
Objective of This Webinar
As social media use continues to increase among consumers, it is important for the pharmaceutical industry to understand this new technology and how its use will likely impact the industry. At this time, while many other industries are using social media to their advantage, pharma has been hesitant to make use of the technology, fearful that the industry is not suited to the two-way conversation inherent in social media and concerned about the legal ramifications of not addressing adverse events encountered through social media.
This program is designed to help attendees understand the various social media formats and the benefits of their use. It will help decode some of the mysteries surrounding social media, present clear facts as to why the discussion surrounding social media and pharma needs to take place and clarify misconceptions that some in the industry may have about the use of social media in pharma. It will also present examples of companies who are developing processes and procedures in response to the use of social media, and of those who have gone a step further, creating and maintaining Web 2.0 sites. Finally, it will examine the FDA’s use of and stance toward the use of social media. The presentation will begin with the basics of social media and then dig deeper into industry use of this tool, touching on recent sound bites regarding the topic, late-breaking news and reportable adverse events found on social media sites.
After viewing the program, attendees will have a greater understanding of social media use as it relates to the pharmaceutical industry.
What You Will Learn
Upon completion of this Webinar, participants should be able to:
- Grasp the importance of social media in today’s society and understand the difference between the top social media forums
- Describe two ways in which social media can create open, two-way communication with patients
- Explain why using social media is not likely to lead to an increase of reported adverse events
Who Will Benefit
This webinar is intended for Clinical Research Associates (CRAs), Principal Investigators, Pharmaceutical Physicians, and Pharmacovigilance Monitors.
Meet Your Presenters
Elizabeth Garrard, PharmD, RPh, is the Chief Safety Officer for Drug Safety Alliance, Inc. Dr. Garrard has more than 30 years of clinical and regulatory experience spanning the pharmaceutical, clinical, hospital and retail industries. She provides leadership in strategic planning, analysis, development, implementation and measurement of all aspects of drug safety medical services including signal management and risk evaluation and mitigation strategy. Prior to joining Drug Safety Alliance, she gained valuable pharmacovigilance experience with GlaxoSmithKline. Her career also includes the development of HIV, oncology and infectious disease pharmaceutical care plans for Coram Healthcare.
Disclosure Statement
Dr. Garrard states that she has no actual or potential financial conflict of interest in relation to this program.
Program Numbers
Association of Clinical Research Professionals
The Association of Clinical Research Professionals (ACRP) provides 1.5 contact hours for the completion of this educational activity with the completion of the online evaluation form. These credits can be used to meet the certification maintenance requirement (Program Number ACRP-2012-REP-312).
Continuing Nursing Education
The California Board of Registered Nursing (Provider Number 11147) approves the Association of Clinical Research Professionals (ACRP) as a provider of continuing nursing education. (Program Number 11147-2012-REP-312).
Accreditation Council for Continuing Medical Education
The Association of Clinical Research Professionals (ACRP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Association of Clinical Research Professionals designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.
Continuing education credits/contact hours are awarded with the completion of an online evaluation form, which must be completed within 30 days after the webinar date. Upon submission of the evaluation form, a link to the printable certificate will be made available on the attendee’s ACRP personal page.